Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 11, 2021
[ Fri, Jun 11th 2021
] - WOPRAI
[ Fri, Jun 11th 2021
] - WOPRAI
Thu, June 10, 2021
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
[ Thu, Jun 10th 2021
] - WOPRAI
Esther Hong Initiated (AXSM) at Strong Buy and Held Target at $112 on, Jun 10th, 2021
Esther Hong of Berenberg, Initiated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $112 on, Jun 10th, 2021.
Esther has made no other calls on AXSM in the last 4 months.
There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Esther's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Esther
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Increased Target to $105 on, Wednesday, May 26th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021
